Actively Recruiting
A Study in Healthy People to Test How Vicadrostat Affects the Heart
Led by Boehringer Ingelheim · Updated on 2026-05-12
45
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective of this trial is to investigate the effect of vicadrostat on the heart compared with placebo in healthy male and female volunteers.
CONDITIONS
Official Title
A Study in Healthy People to Test How Vicadrostat Affects the Heart
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy male or female volunteers as confirmed by medical history, physical exam, vital signs, ECG, and lab tests
- Age between 18 and 50 years inclusive
- Body mass index (BMI) between 18.5 and 29.9 kg/m² inclusive
- Signed written informed consent according to guidelines and local laws
You will not qualify if you...
- Any clinically relevant abnormality found in medical exam, including blood pressure, pulse rate, or ECG
- Repeated systolic blood pressure outside 90 to 140 mmHg, diastolic blood pressure outside 50 to 90 mmHg, or pulse rate outside 45 to 90 bpm
- Any lab test result outside reference range considered clinically relevant
- Any clinically relevant concomitant disease identified by the investigator
- Other unspecified exclusion criteria may apply
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Humanpharmakologisches Zentrum Biberach
Biberach, Germany, 88397
Actively Recruiting
Research Team
B
Boehringer Ingelheim
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here